` SECT B (Sectra AB) vs OMX Stockholm 30 Comparison - Alpha Spread

SECT B
vs
OMX Stockholm 30

Over the past 12 months, SECT B has significantly outperformed OMX Stockholm 30, delivering a return of 26% compared to the OMX Stockholm 30's 5% drop.

Stocks Performance
SECT B vs OMX Stockholm 30

Loading

Performance Gap
SECT B vs OMX Stockholm 30

Loading
SECT B
OMX Stockholm 30
Difference

Performance By Year
SECT B vs OMX Stockholm 30

Loading
SECT B
OMX Stockholm 30
Add Stock

Competitors Performance
Sectra AB vs Peers

OMX Stockholm 30
SECT B
VEEV
PME
DOCS
2413
Add Stock

Sectra AB
Glance View

Economic Moat
None
Market Cap
54.1B SEK
Industry
Health Care

Sectra AB, a Swedish firm with a storied history dating back to 1978, has carved its niche in the dynamic world of medical technology and cybersecurity. Initially making its mark as an innovator within secure communications, the company swiftly recognized the burgeoning potential within the healthcare sector. By blending their prowess in advanced imaging technology with secure data handling, Sectra has established itself as a leader in medical IT systems. Their primary business revolves around the development and delivery of Picture Archiving and Communication Systems (PACS) that streamline the management and storage of medical images. These systems not only enhance diagnostic capabilities but also improve operational efficiencies for healthcare providers. Sectra’s revenue model leans heavily on long-term contracts and service agreements with hospitals and healthcare facilities worldwide, ensuring a steady stream of repeat business. The integration of state-of-the-art cybersecurity measures into their offerings has further cemented their reputation in an industry where data privacy and integrity are paramount. Beyond healthcare, Sectra continues to leverage its expertise in secure communications to cater to governments and defense agencies, providing a diversified income stream. This strategic diversification allows Sectra to remain resilient against the cyclicality of single-market dependencies, securing its position as a robust player in both health and security sectors.

SECT B Intrinsic Value
73.75 SEK
Overvaluation 74%
Intrinsic Value
Price
Back to Top